Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Quintiles to deliver AstraZeneca’s clinical pharmacology studies

Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.

3 Nov 2009

$New drug may help bone fractures heal more quickly after radiation exposure$

New drug may help bone fractures heal more quickly after radiation exposure

A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The study's results will be presented at 1 p.m. today during the American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.

3 Nov 2009

IMC-RT does not benefit breast cancer patients

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

3 Nov 2009

NUVIGIL improves wakefulness in patients with excessive sleepiness associated with shift work disorder

Cephalon, Inc. today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL® (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder (SWD).

3 Nov 2009

ASTRO commends CMS for limiting payment reductions proposed for radiation oncology

ASTRO, the American Society for Radiation Oncology, today praised the Centers for Medicare and Medicaid Services (CMS) for limiting the payment reductions initially proposed for radiation oncology and spreading the remaining cuts over four years.

3 Nov 2009

EpiCept's request for continued listing on the Nasdaq Stock Market granted by Nasdaq Hearings Panel

EpiCept Corporation today announced that a Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market.

3 Nov 2009

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

3 Nov 2009

New imaging technique for treatment of breast cancer

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. The study is examining the utility of three-dimensional thermal tomography in radiation oncology.

3 Nov 2009

BioVex publishes OncoVEX (GM-CSF) Phase 2 study results

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.

2 Nov 2009

superDimension launches the iLogic electromagnetic navigation bronchoscopy tool

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today the launch of the iLogic System for early lung cancer detection and diagnosis. The device is the second generation version of inReach(TM), superDimension's electromagnetic navigation bronchoscopy (ENB) minimally invasive tool.

2 Nov 2009

Blue Cross Blue Shield of Michigan, OPR launch an innovative oncology treatment initiative

Blue Cross Blue Shield of Michigan and Oncology Physician Resource announced today the launch of an innovative oncology treatment initiative aimed at enhancing the quality of care for patients with certain types of cancer.

2 Nov 2009

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

ZirMed®, a national provider of revenue cycle management services for healthcare practices, and leading integrated healthcare technology company Raintree Systems Inc. today announced a working partnership to jointly market their combined solutions to current and prospective customers. As a result of the partnership, ZirMed's flagship revenue cycle management platform will be integrated with Raintree's practice management and Electronic Medical Records (EMR) products, giving users state-of-the-art technology with which to better manage their daily operations.

2 Nov 2009

Sunesis Pharmaceuticals raises $5.0 million through private placement

Sunesis Pharmaceuticals, Inc. today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009.

2 Nov 2009

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.

2 Nov 2009

Asking a few questions can help determine risk for lung cancer

A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire

2 Nov 2009

Oncology News and Research

Further Reading

Quintiles to deliver AstraZeneca’s clinical pharmacology studies

New drug may help bone fractures heal more quickly after radiation exposure

IMC-RT does not benefit breast cancer patients

NUVIGIL improves wakefulness in patients with excessive sleepiness associated with shift work disorder

ASTRO commends CMS for limiting payment reductions proposed for radiation oncology

EpiCept's request for continued listing on the Nasdaq Stock Market granted by Nasdaq Hearings Panel

Extra dose of proton radiation therapy reduces prostate cancer recurrences

New imaging technique for treatment of breast cancer

BioVex publishes OncoVEX (GM-CSF) Phase 2 study results

superDimension launches the iLogic electromagnetic navigation bronchoscopy tool

Blue Cross Blue Shield of Michigan, OPR launch an innovative oncology treatment initiative

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

Sunesis Pharmaceuticals raises $5.0 million through private placement

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

Asking a few questions can help determine risk for lung cancer

InteRNA Technologies and Dana-Farber Cancer Institute team up for cancer research

Medpace signs purchase agreement to acquire Pharma Brains

Intervals between lung cancer diagnosis and treatment may attribute to health care discrepancies

New CyberKnife Robotic Radiosurgery System from Accuray

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News